Research Article
BibTex RIS Cite

Kahve ve çay tüketiminin tip 2 diyabet ve insülin direnci olan bireylerdeki etkisinin kesitsel bir çalışma ile değerlendirilmesi

Year 2021, Volume: 14 Issue: 1, 44 - 55, 30.04.2021
https://doi.org/10.26559/mersinsbd.777961

Abstract

Tüm dünyada yaygın olarak tüketilen çay ve kahvenin tip 2 diyabetli bireylerde glikoz kullanımı ve metabolizmasını etkileyebileceği düşünülmüştür. Amaç: Tip 2 diyabet veya insülin dirençli bireylerde kahve ile çay tüketiminin antropometrik ve biyokimyasal değerlerle ilişkisinin saptaması amaçlanmıştır. Yöntem: Çalışma Ege Üniversitesi Endokrinoloji ve Metabolizma Hastalıkları BD polikliniğine 2015-2016 Aralık tarihleri arasında başvuran (18-65 yaş arası) tip 2 diyabetli ve insülin direnci olan bireylere veri toplama formu ile uygulanarak yürütülmüştür. Bulgular: Gönüllülerin (n=300, yaş ortalaması 45.0) %54.0’ü tip 2 diyabetiktir; %65.0’i oral antidiyabetik, %14.3’ü bazal insülin, %15.6’sı ise multipl enjektabl tedavisi kullanmaktadır. Tıbbi beslenme tedavisinin %62.7’si uygulanmamaktadır. Katılımcıların %48.3’ü Türk kahvesini, %73.0’ü çayı, %84.7’si granül kahveyi şekersiz tüketmektedir. Beden kütle indeksi (BKİ), bel çevresi, yağ oranı ortalaması sırasıyla (n=300) 33.6 kg/m2, (n=299) 108.6 cm, (n=287) %39.1 belirlenmiştir. HbA1c, total kolesterol, trigliserit, HDL kolesterol, LDL kolesterol, sistolik ve diyastolik kan basıncları ortalamaları sırasıyla (n=274) %6.3, (n=252) 207.7 mg/dL, (n=253) 166.8 mg/dL, (n=249) 50.1 mg/dL, (n=247) 126.1 mg/dL, (n=288) 123.7 mmHg, (n=288) 80.3 mmHg olarak saptanmıştır. Bireylerin günlük mL tüketim ortalaması 187.5 7 (n=70) yeşil çay, 564.7 (n=288) siyah çay, 53.0 (n=240) Türk kahvesi, 206.5 (n=115) granül kahvedir. Günlük ≥800 mL siyah çay tüketenlerde <800 mL siyah çay tüketenlere göre vücut yağ oranının normal olma durumu anlamlı olarak yüksek saptanmıştır (p<0.05). Sonuç: Kahveyle çayın etkisini saptamak amacıyla kapsamlı çalışmalara ihtiyaç vardır.

Supporting Institution

Bu çalışma Ege Üniversitesi Bilimsel Araştırma Projeleri Koordinatörlüğü 16/ECZ/001 nolu proje tarafından desteklenmiştir.

Project Number

16/ECZ/001 nolu proje

Thanks

İstatistiksel analiz konusunda desteklerinden dolayı Dr. Kıvanç Yüksel’e teşekkür ederiz

References

  • Kaynaklar 1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87(1): 4-14.
  • 2. Evert AB, Boucher JL, Cypress M et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2014;37(1):120-143.
  • 3. Ra A, Polansky MM. Tea enhances insulin activity. J Agric Food Chem 2002;50(24):7182-7186.
  • 4. Higdon JV, Frei B. Tea Catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sc Nut 2003;43(1):89-143.
  • 5. Lane JD, Barkauskas CE, Surwit RS, Feinglos MN. caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 2004;27(8):2047-2048.
  • 6. Kobayashi Y, Suzuki M, Satsu H et al. Green tea polyphenols ınhibit the sodium-dependent glucose transporter of ıntestinal epithelial cells by a competitive mechanism. J Agric Food Chem 2000; 48(11): 5618-5623.
  • 7. Shimizu M, Kobayashi Y, Suzuki M, Satsu H, Miyamoto Y. Regulation of intestinal glucose transport by tea catechins. BioFactors 2000;13(1-4):61–65.
  • 8. Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 2000;141(3):980-987.
  • 9. Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 2002;277(38):34933-34940.
  • 10. Kao YH, Chang HH, Lee MJ, Chen CL. Tea, obesity, and diabetes. Mol Nutr Food Res 2006;50(2):188-210.
  • 11. Tuomilehto J, Hu G, Bidel S, Lindström J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 2004;291(10):1213-1219.
  • 12. Arion WJ, Canfield WK, Ramos FC et al. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 1997;339(2):315-322.
  • 13. Herling AW, Burger H, Schubert G, Hemmerle H, Schaefer H, Kramer W. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur J Pharmacol 1999;386(1):75-82.
  • 14. Li Y, Kim J, Li J et al. Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway. Biochem Biophys Res Commun 2005;336(2):430-437.
  • 15. Muthusamy VS, Anand S, Sangeetha KN, Sujatha S, Arun B, Lakshmi BS. Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3T3-L1 adipocytes through PTP1B inhibition. Chem Biol Interact 2008;174(1):69-78.
  • 16. Prabhakar PK, Doble M. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine 2009;16(12):1119-1126.
  • 17. Egawa T, Hamada T, Kameda N et al. Caffeine acutely activates 5'adenosine monophosphate-activated protein kinase and increases insulin-independent glucose transport in rat skeletal muscles. Metabolism 2009;58(11):1609–1617.
  • 18. Vitaglione P, Morisco F, Mazzone G et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010;52(5):1652-1661.
  • 19. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26(4):1147-1152.
  • 20. Belin RJ, He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res 2007;20(2):107-129.
  • 21. Craig CL, Marshall AL, Sjöström M et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35(8):1381–1395.
  • 22. Öztürk M., Üniversitede eğitim-öğretim gören öğrencilerde uluslararası fiziksel aktivite anketinin geçerliliği ve güvenirliği ve fiziksel aktivite düzeylerinin belirlenmesi (Yüksek Lisans Tezi), Hülya Arıkan, Yayımlanmamış tezi, Ankara, 2005.
  • 23. American Diabetes Association. Standards of Medical Care in Diabetes-2015. Diabetes Care 2014; 38(1):21-24.
  • 24. Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One 2014;9(3):e91163.
  • 25. Williams CJ, Fargnoli JL, Hwang JJ et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 2008;31(3):504-507.
  • 26. Bhaktha G, Nayak BS, Mayya S, Shantaram M. Relationship of Caffeine with Adiponectin and Blood Sugar Levels in Subjects with and without Diabetes. J Clin Diagn Res 2015;9(1):BC01-BC3.
  • 27. Hosoda K, Wang MF, Liao ML et al. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 2003; 26(6): 1714–1718.
  • 28. Sözlü S, Yılmaz B, Acar Tek N. Kahve tüketimi ve bazı hastalıklarla ilişkisi: son yıllarda yapılan insan temelli araştırmaların irdelenmesi. SDÜ Sağlık Bilimleri Dergisi. 2017;8(2): 33-39.
  • 29. Shi L, Brunius C, Johansson I et al. Plasma metabolite biomarkers of boiled and filtered coffee intake and their association with type 2 diabetes risk. J Intern Med 2020;287(4):405-421.
  • 30. Dincer C, T Apaydın D, Gogas Y. Endocrine Effects of Coffee Consumption. Turk J Endocrinol Metab 2020;24(1):72-86.
  • 31. Saltan FZ, H Kaya. Kahve: Bir Farmakognozik Derleme. Fabad J Pharm Sci 2018;43(3):279-289.

Evaluation of effect of coffee and tea consumption on individuals with type 2 diabetes and insulin resistance: A cross-sectional study

Year 2021, Volume: 14 Issue: 1, 44 - 55, 30.04.2021
https://doi.org/10.26559/mersinsbd.777961

Abstract

Tea and coffee, widely consumed around the world, were thought to affect glucose usage and metabolism in individuals with type 2 diabetes. Objective: To determine the relationship between coffee and tea consumption with anthropometric and biochemical values individuals with type 2 diabetes and insulin resistance was aimed. Method: The study was conducted with face-to-face questionnaires with individuals (ages 18-65), having type 2 diabetes or insulin resistance who applied to the Ege University Endocrinology and Metabolic Diseases Clinic between December 2015-2016. Results: Volunteers (n=300, average age 45.0) had type 2 diabetic (54.0%) uses oral antidiabetic (65.0%), basal insulin (14.3%), multiple injectable (15.6%) therapies. Medical nutrition therapy was not performed (62.7%). The participants consume Turkish coffee (48.3%) tea (73.0%) granulated coffee (84.7%) without sugar. Averages of Body Mass Index, waist circumference, fat ratio mean was determined as (n=300) 33.6 kg / m2, (n=299) 108.6 cm, (n=287) 39.1% respectively. HbA1c, total cholesterol, triglyceride, HDL cholesterol, LDL cholesterol, systolic and diastolic blood pressure averages were (n=274) 6.3%, (n=252) 207.7 mg / dL, (n=253) 166.8 mg / dL, (n=249) 50.1 mg / dL, (n=247) 126.1 mg / dL, (n=288) 123.7 mmHg, (n=288) 80.3 mmHg respectively. Individuals consumed mL/daily average of 187.5 7 (n=70) green tea, 564.7 (n=288) black tea, 53.0 (n=240) Turkish coffee, 206.5 (n=115) granulated coffee. The normal state of body fat was found to be significantly higher in those who consumed ≥800 mL of black tea daily, than those consumed <800 mL (p <0.05). Conclusion: Further studies are needed to determine effects of tea and coffee.

Project Number

16/ECZ/001 nolu proje

References

  • Kaynaklar 1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87(1): 4-14.
  • 2. Evert AB, Boucher JL, Cypress M et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2014;37(1):120-143.
  • 3. Ra A, Polansky MM. Tea enhances insulin activity. J Agric Food Chem 2002;50(24):7182-7186.
  • 4. Higdon JV, Frei B. Tea Catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sc Nut 2003;43(1):89-143.
  • 5. Lane JD, Barkauskas CE, Surwit RS, Feinglos MN. caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 2004;27(8):2047-2048.
  • 6. Kobayashi Y, Suzuki M, Satsu H et al. Green tea polyphenols ınhibit the sodium-dependent glucose transporter of ıntestinal epithelial cells by a competitive mechanism. J Agric Food Chem 2000; 48(11): 5618-5623.
  • 7. Shimizu M, Kobayashi Y, Suzuki M, Satsu H, Miyamoto Y. Regulation of intestinal glucose transport by tea catechins. BioFactors 2000;13(1-4):61–65.
  • 8. Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 2000;141(3):980-987.
  • 9. Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 2002;277(38):34933-34940.
  • 10. Kao YH, Chang HH, Lee MJ, Chen CL. Tea, obesity, and diabetes. Mol Nutr Food Res 2006;50(2):188-210.
  • 11. Tuomilehto J, Hu G, Bidel S, Lindström J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 2004;291(10):1213-1219.
  • 12. Arion WJ, Canfield WK, Ramos FC et al. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 1997;339(2):315-322.
  • 13. Herling AW, Burger H, Schubert G, Hemmerle H, Schaefer H, Kramer W. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur J Pharmacol 1999;386(1):75-82.
  • 14. Li Y, Kim J, Li J et al. Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway. Biochem Biophys Res Commun 2005;336(2):430-437.
  • 15. Muthusamy VS, Anand S, Sangeetha KN, Sujatha S, Arun B, Lakshmi BS. Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3T3-L1 adipocytes through PTP1B inhibition. Chem Biol Interact 2008;174(1):69-78.
  • 16. Prabhakar PK, Doble M. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine 2009;16(12):1119-1126.
  • 17. Egawa T, Hamada T, Kameda N et al. Caffeine acutely activates 5'adenosine monophosphate-activated protein kinase and increases insulin-independent glucose transport in rat skeletal muscles. Metabolism 2009;58(11):1609–1617.
  • 18. Vitaglione P, Morisco F, Mazzone G et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010;52(5):1652-1661.
  • 19. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26(4):1147-1152.
  • 20. Belin RJ, He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res 2007;20(2):107-129.
  • 21. Craig CL, Marshall AL, Sjöström M et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35(8):1381–1395.
  • 22. Öztürk M., Üniversitede eğitim-öğretim gören öğrencilerde uluslararası fiziksel aktivite anketinin geçerliliği ve güvenirliği ve fiziksel aktivite düzeylerinin belirlenmesi (Yüksek Lisans Tezi), Hülya Arıkan, Yayımlanmamış tezi, Ankara, 2005.
  • 23. American Diabetes Association. Standards of Medical Care in Diabetes-2015. Diabetes Care 2014; 38(1):21-24.
  • 24. Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One 2014;9(3):e91163.
  • 25. Williams CJ, Fargnoli JL, Hwang JJ et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 2008;31(3):504-507.
  • 26. Bhaktha G, Nayak BS, Mayya S, Shantaram M. Relationship of Caffeine with Adiponectin and Blood Sugar Levels in Subjects with and without Diabetes. J Clin Diagn Res 2015;9(1):BC01-BC3.
  • 27. Hosoda K, Wang MF, Liao ML et al. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 2003; 26(6): 1714–1718.
  • 28. Sözlü S, Yılmaz B, Acar Tek N. Kahve tüketimi ve bazı hastalıklarla ilişkisi: son yıllarda yapılan insan temelli araştırmaların irdelenmesi. SDÜ Sağlık Bilimleri Dergisi. 2017;8(2): 33-39.
  • 29. Shi L, Brunius C, Johansson I et al. Plasma metabolite biomarkers of boiled and filtered coffee intake and their association with type 2 diabetes risk. J Intern Med 2020;287(4):405-421.
  • 30. Dincer C, T Apaydın D, Gogas Y. Endocrine Effects of Coffee Consumption. Turk J Endocrinol Metab 2020;24(1):72-86.
  • 31. Saltan FZ, H Kaya. Kahve: Bir Farmakognozik Derleme. Fabad J Pharm Sci 2018;43(3):279-289.
There are 31 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Articles
Authors

Doğa Peksever 0000-0003-2719-2412

Ilgın Yıldırım Şimşir 0000-0002-6801-8499

Reci Meseri 0000-0002-2482-3066

Yrd. Doç. Dr. M Zeki Haznedaroğlu 0000-0002-5569-7891

Project Number 16/ECZ/001 nolu proje
Publication Date April 30, 2021
Submission Date August 13, 2020
Acceptance Date November 16, 2020
Published in Issue Year 2021 Volume: 14 Issue: 1

Cite

APA Peksever, D., Yıldırım Şimşir, I., Meseri, R., Haznedaroğlu, Y. D. D. M. Z. (2021). Kahve ve çay tüketiminin tip 2 diyabet ve insülin direnci olan bireylerdeki etkisinin kesitsel bir çalışma ile değerlendirilmesi. Mersin Üniversitesi Sağlık Bilimleri Dergisi, 14(1), 44-55. https://doi.org/10.26559/mersinsbd.777961
AMA Peksever D, Yıldırım Şimşir I, Meseri R, Haznedaroğlu YDDMZ. Kahve ve çay tüketiminin tip 2 diyabet ve insülin direnci olan bireylerdeki etkisinin kesitsel bir çalışma ile değerlendirilmesi. Mersin Univ Saglık Bilim derg. April 2021;14(1):44-55. doi:10.26559/mersinsbd.777961
Chicago Peksever, Doğa, Ilgın Yıldırım Şimşir, Reci Meseri, and Yrd. Doç. Dr. M Zeki Haznedaroğlu. “Kahve Ve çay tüketiminin Tip 2 Diyabet Ve insülin Direnci Olan Bireylerdeki Etkisinin Kesitsel Bir çalışma Ile değerlendirilmesi”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 14, no. 1 (April 2021): 44-55. https://doi.org/10.26559/mersinsbd.777961.
EndNote Peksever D, Yıldırım Şimşir I, Meseri R, Haznedaroğlu YDDMZ (April 1, 2021) Kahve ve çay tüketiminin tip 2 diyabet ve insülin direnci olan bireylerdeki etkisinin kesitsel bir çalışma ile değerlendirilmesi. Mersin Üniversitesi Sağlık Bilimleri Dergisi 14 1 44–55.
IEEE D. Peksever, I. Yıldırım Şimşir, R. Meseri, and Y. D. D. M. Z. Haznedaroğlu, “Kahve ve çay tüketiminin tip 2 diyabet ve insülin direnci olan bireylerdeki etkisinin kesitsel bir çalışma ile değerlendirilmesi”, Mersin Univ Saglık Bilim derg, vol. 14, no. 1, pp. 44–55, 2021, doi: 10.26559/mersinsbd.777961.
ISNAD Peksever, Doğa et al. “Kahve Ve çay tüketiminin Tip 2 Diyabet Ve insülin Direnci Olan Bireylerdeki Etkisinin Kesitsel Bir çalışma Ile değerlendirilmesi”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 14/1 (April 2021), 44-55. https://doi.org/10.26559/mersinsbd.777961.
JAMA Peksever D, Yıldırım Şimşir I, Meseri R, Haznedaroğlu YDDMZ. Kahve ve çay tüketiminin tip 2 diyabet ve insülin direnci olan bireylerdeki etkisinin kesitsel bir çalışma ile değerlendirilmesi. Mersin Univ Saglık Bilim derg. 2021;14:44–55.
MLA Peksever, Doğa et al. “Kahve Ve çay tüketiminin Tip 2 Diyabet Ve insülin Direnci Olan Bireylerdeki Etkisinin Kesitsel Bir çalışma Ile değerlendirilmesi”. Mersin Üniversitesi Sağlık Bilimleri Dergisi, vol. 14, no. 1, 2021, pp. 44-55, doi:10.26559/mersinsbd.777961.
Vancouver Peksever D, Yıldırım Şimşir I, Meseri R, Haznedaroğlu YDDMZ. Kahve ve çay tüketiminin tip 2 diyabet ve insülin direnci olan bireylerdeki etkisinin kesitsel bir çalışma ile değerlendirilmesi. Mersin Univ Saglık Bilim derg. 2021;14(1):44-55.

MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.

Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.

Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.

Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.

Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.

Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.

154561545815459

Creative Commons Lisansı
This work is licensed with Attribution-NonCommercial 4.0 International.